rituximab versus azathioprine
Showing 1 - 25 of >10,000
Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Feb 9, 2022
Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of
Not yet recruiting
- Acute Demyelinating Syndrome
- Immediate Azathioprine (1st attack)
- +2 more
-
Besançon, France
- +8 more
Sep 14, 2022
Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)
Recruiting
- Immune Thrombocytopenia Purpura
- Dexamethasone
- +4 more
-
Cairo, EgyptEL-Kasr elineiy
May 6, 2023
Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)
Not yet recruiting
- Atopic Dermatitis
- Baricitinib 4 MG
- Azathioprine 1.5-2.5 mg/kg
-
Sari, Mazandaran, Iran, Islamic Republic ofIran
Aug 1, 2023
Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)
Not yet recruiting
- Chronic Graft Versus Host Disease
-
Atlanta, GeorgiaNorthside Hospital
Sep 21, 2023
Crohn Disease Trial (Azathioprine + infliximab, Intestinal resection)
Not yet recruiting
- Crohn Disease
- Azathioprine + infliximab
- Intestinal resection
- (no location specified)
Oct 14, 2022
Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +
Not yet recruiting
- Marginal Zone Lymphoma
- Mosunetuzumab + Lenalidomide
- +3 more
- (no location specified)
Aug 16, 2023
Nephrotic Syndrome in Children Trial in Chongqing (Rituximab, Mycophenolate Mofetil)
Recruiting
- Nephrotic Syndrome in Children
- Rituximab
- Mycophenolate Mofetil
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
May 3, 2023
Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)
Not yet recruiting
- Primary Ocular Adnexal MALT Lymphoma
- Rituximab
- Involved Site Radiation Therapy
- (no location specified)
Sep 26, 2023
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis Trial in Worldwide
Completed
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- +2 more
- Rituximab
- Azathioprine
-
Los Angeles, California
- +37 more
Feb 18, 2022
Splenic Marginal Zone Lymphoma Trial in Worldwide (Rituximab, Zanubrutinib)
Not yet recruiting
- Splenic Marginal Zone Lymphoma
-
Aarhus, Denmark
- +4 more
Feb 17, 2023
Pharmacological Action Trial (Rituximab, Dexamethasone)
Not yet recruiting
- Pharmacological Action
- (no location specified)
Sep 22, 2022
Steroid-Dependent Nephrotic Syndrome, Steroid-Sensitive Nephrotic Syndrome Trial in Paris (single infusion of Rituximab, single
Not yet recruiting
- Steroid-Dependent Nephrotic Syndrome
- Steroid-Sensitive Nephrotic Syndrome
- single infusion of Rituximab
- single infusion of Obinutuzumab
-
Paris, FranceRobert Debre Hospital
Mar 14, 2023
Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)
Completed
- Renal Transplant
- Rituximab
- intravenous immune globulin
-
Seoul, Korea, Republic of
- +1 more
Oct 25, 2022
Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)
Not yet recruiting
- Large B-Cell Lymphoma
- Glofitamab
- +5 more
-
Xi'an, ChinaFirst Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023
Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy Trial in Moscow (mycophenolate mofetil 2 g per day,
Recruiting
- Lymphocytic Myocarditis (Disorder)
- +4 more
- mycophenolate mofetil 2 g per day
- azathioprine of 150 [75; 150] mg per day
-
Moscow, Bol'shaya Pirogovskaya Street 6, 1 Building ,, Russian FederationI.M. Sechenov First Moscow State Medical University (Sechenov Un
Feb 2, 2022
Nephrotic Syndrome Steroid-Dependent Trial in Genova (Rituximab Biosimilar)
Recruiting
- Nephrotic Syndrome Steroid-Dependent
- Rituximab Biosimilar
-
Genova, ItalyIRCCS G. Gaslini
Dec 19, 2022
Relapsed/Refractory Marginal Zone Lymphoma Trial in China (Orelabrutinib, Lenalidomide, Rituximab)
Not yet recruiting
- Relapsed/Refractory Marginal Zone Lymphoma
- Orelabrutinib
- +3 more
-
Guangzhou, Guangdong, China
- +10 more
Oct 8, 2023
Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Marginal Zone Lymphoma
- Zanubrutinib
- +3 more
-
Westbury, New YorkClinical Research Alliance, Inc.
Nov 14, 2022
Interstitial Lung Disease, Scleroderma, Idiopathic Inflammatory Myositis Trial in London (Rituximab, Cyclophosphamide)
Completed
- Interstitial Lung Disease
- +3 more
-
London, United KingdomRoyal Brompton Hospital
Oct 6, 2021
Interstitial Lung Disease, Scleroderma Trial in Assiut (Rituximab, IL6 inhibitor)
Completed
- Interstitial Lung Disease
- Scleroderma
- Rituximab
- IL6 inhibitor
-
Assiut, Yes, EgyptManal Hassanien
Jul 18, 2023
Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)
Active, not recruiting
- Diffuse Large B-cell Lymphoma
- Rituximab
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Ruijin Hospital
Dec 1, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Nemtabrutinib
- +7 more
- (no location specified)
Nov 30, 2022
Therapeutic Equivalency Trial in Leicester, Manchester (Azathioprine 50Mg Tab, Azathioprine 10mg/mL oral suspension)
Completed
- Therapeutic Equivalency
- Azathioprine 50Mg Tab
- Azathioprine 10mg/mL oral suspension
-
Leicester, Leicestershire, United Kingdom
- +1 more
Jun 21, 2021